Expert versus generalist inserters for peripheral intravenous catheter insertion: A pilot randomised controlled trial

Trials

Volumn 19, Issue 1, 2018, Pages

  Marsh, Nicole ^a,b,c   Webster, Joan ^a,b,d   Larsen, Emily ^a,b,c   Genzel, Jodie ^a,b,c   Cooke, Marie ^b,c   Mihala, Gabor ^b,c   Cadigan, Sue ^a   Rickard, Claire M ^a,b,c  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

^c GRIFFITH UNIVERSITY   (Australia)

^d QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Intravenous; Phlebitis; Randomised controlled trial; Vascular access devices

Indexed keywords

ADVERSE DEVICE EFFECT; AGED; CATHETER INFECTION; CATHETERIZATION; COMPARATIVE STUDY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DEVICES; ECONOMICS; FEMALE; HUMAN; INDWELLING CATHETER; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PILOT STUDY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL;

AGED; CATHETER-RELATED INFECTIONS; CATHETERIZATION, PERIPHERAL; CATHETERS, INDWELLING; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT SATISFACTION; PILOT PROJECTS;

EID: 85054954442     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/s13063-018-2946-3     Document Type: Article

References (31)

1. Rickard CM, Ray-Barruel G. Peripheral intravenous catheter assessment: beyond phlebitis. Lancet Haematol. 2017;4(9):e402-3. https://doi.org/10.1016/S2352-3026(17)30145-X.
2. Chopra V, Flanders SA, Saint S, Woller SC, O'Grady NP, Safdar N, et al. The Michigan Appropriateness Guide for Intravenous Catheters (MAGIC): results from a multispecialty panel using the RAND/UCLA appropriateness method. Ann Intern Med. 2015;163(Suppl 6):S1-40. https://doi.org/10.7326/M15-0744.
3. Royer TF. Improving short peripheral IV outcomes: a clinical trial of two securement methods. JAVA. 2003;8(4):45-9. https://doi.org/10.2309/155288503774651805.
4. Smith B. Peripheral intravenous catheter dwell times: a comparison of 3 securement methods for implementation of a 96-hour scheduled change protocol. J Infus Nurs. 2006;29(1):14-7.
5. Rickard CM, McCann D, Munnings J, McGrail MR. Routine resite of peripheral intravenous devices every 3 days did not reduce complications compared with clinically indicated resite: a randomised controlled trial. BMC Med. 2010;8:53. https://doi.org/10.1186/1741-7015-8-53.
6. Carr PJ, Glynn RW, Dineen B, Kropmans TJ. A pilot intravenous cannulation team: an Irish perspective. Br J Nurs. 2010;19(10):S19-27.
7. Bosma TL, Jewesson PJ. An infusion program resource nurse consult service: our experience in a major Canadian teaching hospital. J Infus Nurs. 2002;25(5):310-5.
8. Carr PJ, Higgins NS, Cooke ML, Mihala G, Rickard CM. Vascular access specialist teams for device insertion and prevention of failure. Cochrane Database Syst Rev. 2018;20(3):CD011429. https://doi.org/10.1002/14651858.CD011429.pub2.
9. Hadaway L, Dalton L, Mercanti-Erieg L. Infusion teams in acute care hospitals: call for a business approach: an Infusion Nurses Society white paper. J Infus Nurs. 2013;36(5):356-60. https://doi.org/10.1097/NAN.0b013e3182a123a9.
10. Robertson KJ. The role of the i.v. specialist in health care reform. J Intraven Nurs. 1995;18(3):130-44.
11. Hawes ML. A proactive approach to combating venous depletion in the hospital setting. J Infus Nurs. 2007;30(1):33-44.
12. Palefski SS, Stoddard GJ. The infusion nurse and patient complication rates of peripheral-short catheters: a prospective evaluation. J Intraven Nurs. 2001;24(2):113-23.
13. Cooke M, Ullman AJ, Ray-Barruel G, Wallis M, Corley A, Rickard CM. Not "just" an intravenous line: consumer perspectives on peripheral intravenous cannulation (PIVC). An international cross-sectional survey of 25 countries. PLoS One. 2018;13(2):e0193436. https://doi.org/10.1371/journal.pone.0193436.
14. Wallis MC, McGrail M, Webster J, Marsh N, Gowardman J, Playford EG, et al. Risk factors for peripheral intravenous catheter failure: a multivariate analysis of data from a randomized controlled trial. Infect Control Hosp Epidemiol. 2014;35(1):63-8. https://doi.org/10.1086/674398.
15. Hunter MR. Development of a vascular access team in an acute care setting. J Infus Nurs. 2003;26(2):86-91.
16. Tomford JW, Hershey CO, McLaren CE, Porter DK, Cohen DI. Intravenous therapy team and peripheral venous catheter-associated complications. A prospective controlled study. Arch Intern Med. 1984;144(6):1191-4.
17. Scalley RD, Van CS, Cochran RS. The impact of an i.v. team on the occurrence of intravenous-related phlebitis. A 30-month study. J Intraven Nurs. 1992;15(2):100-9.
18. Soifer NE, Borzak S, Edlin BR, Weinstein RA. Prevention of peripheral venous catheter complications with an intravenous therapy team: a randomized controlled trial. Arch Intern Med. 1998;158(5):473-7.
19. Bai XH, Zang S, Yu L. A comparison of two intravenous infusion devices in lung carcinoma patients receiving combined radiotherapy and chemotherapy. J Cancer Res Ther. 2013;9(4):664-7. https://doi.org/10.4103/0973-1482.126475.
20. Miller JM, Goetz AM, Squier C, Muder RR. Reduction in nosocomial intravenous device-related bacteremias after institution of an intravenous therapy team. J Intraven Nurs. 1996;19(2):103-6.
21. Marsh N, Webster J, Cooke M, Rickard CM. The RELIABLE trial (RELiable Intravenous Access By Line Experts): a pilot randomised controlled trial protocol of expert versus generalist peripheral intravenous catheter insertion. Vascular Access. 2017;3(2):3-7.
22. Hertzog MA. Considerations in determining sample size for pilot studies. Res Nurs Health. 2008;31(2):180-91. https://doi.org/10.1002/nur.20247.
23. Julious SA. Sample size of 12 per group rule of thumb for a pilot study. Pharm Stat. 2005;4(4):287-91. https://doi.org/10.1002/pst.185.
24. O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, et al. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control. 2011;39(4, Suppl 1):S1-34.
25. Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med. 1977;296(23):1305-9.
26. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap) - a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377-81. https://doi.org/10.1016/j.jbi.2008.08.010.
27. Hallam C, Weston V, Denton A, Hill S, Bodenham A, Dunn H, et al. Development of the UK Vessel Health and Preservation (VHP) framework: a multi-organisational collaborative. J Infect Prev. 2016;17(2):65-72. https://doi.org/10.1177/1757177415624752.
28. Jackson T, Hallam C, Corner T, Hill S. Right line, right patient, right time: every choice matters. Br J Nurs. 2013;22(Sup5):S24-8.
29. Vizcarra C, Cassutt C, Corbitt N, Richardson D, Runde D, Stafford K. Recommendations for improving safety practices with short peripheral catheters. J Infus Nurs. 2014;37(2):121-4. https://doi.org/10.1097/NAN.0000000000000028.
30. Béïque L, Zvonar R. Addressing concerns about changing the route of antimicrobial administration from intravenous to oral in adult inpatients. Can J Hosp Pharm. 2015;68(4):318-26.
31. Marsh N, Webster J, Larsen E, Cooke M, Mihala G, Rickard CM. Observational study of peripheral intravenous catheter outcomes in adult hospitalized patients: a multivariable analysis of peripheral intravenous catheter failure. J Hosp Med. 2017:E1-7. https://doi.org/10.12788/jhm.2867.